APO RESEARCH · REPORT
Anti-Peptic Ulcer Drugs
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
Product & engineering
Understand the product.
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
Selected research
Market Structure
Global Anti-Peptic Ulcer Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
Global Anti-Peptic Ulcer Drugs key players include AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, etc. Global top five players hold a share about 50%.
In terms of product, the segment includes Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs. And in terms of application, the application includes Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD).
Read the full market overview
Report Includes
This report provides an overview of the global Anti-Peptic Ulcer Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Anti-Peptic Ulcer Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Anti-Peptic Ulcer Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Anti-Peptic Ulcer Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Anti-Peptic Ulcer Drugs Segment by Company
AstraZeneca
Ask-pharm
Takeda
Yangtze River Pharm
Shandong Luoxin
Huadong Medicine
Changzhou Siyao
Beijing Yuekang
Guangdong Dahua
Xian Janssen
Anti-Peptic Ulcer Drugs Segment by Type
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Ulcer Protective Drugs
Anti-Peptic Ulcer Drugs Segment by Application
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
Anti-Peptic Ulcer Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Peptic Ulcer Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Peptic Ulcer Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Peptic Ulcer Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Anti-Peptic Ulcer Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-Peptic Ulcer Drugs industry.
Chapter 3: Detailed analysis of Anti-Peptic Ulcer Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Peptic Ulcer Drugsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Proton Pump Inhibitors (PPIs)
- Potassium-Competitive Acid Blockers (P-CAB)
- Antacids
- H2 Antagonists
- Ulcer Protective Drugs
Applications
- Gastritis
- Gastric Ulcers
- Duodenal Ulcers
- Gastroesophageal Reflux Disease (GERD)
Companies covered
- AstraZeneca
- Ask-pharm
- Takeda
- Yangtze River Pharm
- Shandong Luoxin
- Huadong Medicine
- Changzhou Siyao
- Beijing Yuekang
- Guangdong Dahua
- Xian Janssen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Proton Pump Inhibitors (PPIs)
- 1.2.3 Potassium-Competitive Acid Blockers (P-CAB)
- 1.2.4 Antacids
- 1.2.5 H2 Antagonists
- 1.2.6 Ulcer Protective Drugs
- 1.3 Market Analysis by Application
- 1.3.1 Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Gastritis
- 1.3.3 Gastric Ulcers
- 1.3.4 Duodenal Ulcers
- 1.3.5 Gastroesophageal Reflux Disease (GERD)
- 1.4 Global Market Growth Prospects
- 1.5 Global Anti-Peptic Ulcer Drugs Growth Trends by Region
- 1.5.1 Global Anti-Peptic Ulcer Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Anti-Peptic Ulcer Drugs Market Size by Region (2021-2026)
- 1.5.3 Anti-Peptic Ulcer Drugs Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Anti-Peptic Ulcer Drugs Market Dynamics
- 2.1 Anti-Peptic Ulcer Drugs Industry Trends
- 2.2 Anti-Peptic Ulcer Drugs Industry Drivers
- 2.3 Anti-Peptic Ulcer Drugs Industry Opportunities and Challenges
- 2.4 Anti-Peptic Ulcer Drugs Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Anti-Peptic Ulcer Drugs Revenue by Company (2021-2026)
- 3.2 Global Anti-Peptic Ulcer Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Anti-Peptic Ulcer Drugs Key Company Head office and Area Served
- 3.4 Global Anti-Peptic Ulcer Drugs Company, Product Type & Application
- 3.5 Global Anti-Peptic Ulcer Drugs Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Anti-Peptic Ulcer Drugs Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Anti-Peptic Ulcer Drugs Players Market Share by Revenue in 2025
- 3.6.3 2025 Anti-Peptic Ulcer Drugs Tier 1, Tier 2, and Tier 3
4 Anti-Peptic Ulcer Drugs Market by Type
- 4.1 Global Anti-Peptic Ulcer Drugs Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Anti-Peptic Ulcer Drugs Market Size by Type (2021-2032)
- 4.3 Global Anti-Peptic Ulcer Drugs Market Size Share by Type (2021-2032)
5 Anti-Peptic Ulcer Drugs Market by Application
- 5.1 Global Anti-Peptic Ulcer Drugs Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Anti-Peptic Ulcer Drugs Market Size by Application (2021-2032)
- 5.3 Global Anti-Peptic Ulcer Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 AstraZeneca
- 6.1.1 AstraZeneca Company Information
- 6.1.2 AstraZeneca Business Overview
- 6.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 AstraZeneca Anti-Peptic Ulcer Drugs Product Portfolio
- 6.1.5 AstraZeneca Recent Developments
- 6.2 Ask-pharm
- 6.2.1 Ask-pharm Company Information
- 6.2.2 Ask-pharm Business Overview
- 6.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Ask-pharm Anti-Peptic Ulcer Drugs Product Portfolio
- 6.2.5 Ask-pharm Recent Developments
- 6.3 Takeda
- 6.3.1 Takeda Company Information
- 6.3.2 Takeda Business Overview
- 6.3.3 Takeda Anti-Peptic Ulcer Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Takeda Anti-Peptic Ulcer Drugs Product Portfolio
- 6.3.5 Takeda Recent Developments
- 6.4 Yangtze River Pharm
- 6.4.1 Yangtze River Pharm Company Information
- 6.4.2 Yangtze River Pharm Business Overview
- 6.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Yangtze River Pharm Anti-Peptic Ulcer Drugs Product Portfolio
- 6.4.5 Yangtze River Pharm Recent Developments
- 6.5 Shandong Luoxin
- 6.5.1 Shandong Luoxin Company Information
- 6.5.2 Shandong Luoxin Business Overview
- 6.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Shandong Luoxin Anti-Peptic Ulcer Drugs Product Portfolio
- 6.5.5 Shandong Luoxin Recent Developments
- 6.6 Huadong Medicine
- 6.6.1 Huadong Medicine Company Information
- 6.6.2 Huadong Medicine Business Overview
- 6.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Huadong Medicine Anti-Peptic Ulcer Drugs Product Portfolio
- 6.6.5 Huadong Medicine Recent Developments
- 6.7 Changzhou Siyao
- 6.7.1 Changzhou Siyao Company Information
- 6.7.2 Changzhou Siyao Business Overview
- 6.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Changzhou Siyao Anti-Peptic Ulcer Drugs Product Portfolio
- 6.7.5 Changzhou Siyao Recent Developments
- 6.8 Beijing Yuekang
- 6.8.1 Beijing Yuekang Company Information
- 6.8.2 Beijing Yuekang Business Overview
- 6.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Beijing Yuekang Anti-Peptic Ulcer Drugs Product Portfolio
- 6.8.5 Beijing Yuekang Recent Developments
- 6.9 Guangdong Dahua
- 6.9.1 Guangdong Dahua Company Information
- 6.9.2 Guangdong Dahua Business Overview
- 6.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Guangdong Dahua Anti-Peptic Ulcer Drugs Product Portfolio
- 6.9.5 Guangdong Dahua Recent Developments
- 6.10 Xian Janssen
- 6.10.1 Xian Janssen Company Information
- 6.10.2 Xian Janssen Business Overview
- 6.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Xian Janssen Anti-Peptic Ulcer Drugs Product Portfolio
- 6.10.5 Xian Janssen Recent Developments
7 North America
- 7.1 North America Anti-Peptic Ulcer Drugs Market Size (2021-2032)
- 7.2 North America Anti-Peptic Ulcer Drugs Market Size by Type
- 7.2.1 North America Anti-Peptic Ulcer Drugs Market Size by Type (2021-2026)
- 7.2.2 North America Anti-Peptic Ulcer Drugs Market Size by Type (2027-2032)
- 7.2.3 North America Anti-Peptic Ulcer Drugs Market Share by Type (2021-2032)
- 7.3 North America Anti-Peptic Ulcer Drugs Market Size by Application
- 7.3.1 North America Anti-Peptic Ulcer Drugs Market Size by Application (2021-2026)
- 7.3.2 North America Anti-Peptic Ulcer Drugs Market Size by Application (2027-2032)
- 7.3.3 North America Anti-Peptic Ulcer Drugs Market Share by Application (2021-2032)
- 7.4 North America Anti-Peptic Ulcer Drugs Market Size by Country
- 7.4.1 North America Anti-Peptic Ulcer Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Anti-Peptic Ulcer Drugs Market Size by Country (2021-2026)
- 7.4.3 North America Anti-Peptic Ulcer Drugs Market Size by Country (2027-2032)
- 7.4.4 North America Anti-Peptic Ulcer Drugs Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Anti-Peptic Ulcer Drugs Market Size (2021-2032)
- 8.2 Europe Anti-Peptic Ulcer Drugs Market Size by Type
- 8.2.1 Europe Anti-Peptic Ulcer Drugs Market Size by Type (2021-2026)
- 8.2.2 Europe Anti-Peptic Ulcer Drugs Market Size by Type (2027-2032)
- 8.2.3 Europe Anti-Peptic Ulcer Drugs Market Share by Type (2021-2032)
- 8.3 Europe Anti-Peptic Ulcer Drugs Market Size by Application
- 8.3.1 Europe Anti-Peptic Ulcer Drugs Market Size by Application (2021-2026)
- 8.3.2 Europe Anti-Peptic Ulcer Drugs Market Size by Application (2027-2032)
- 8.3.3 Europe Anti-Peptic Ulcer Drugs Market Share by Application (2021-2032)
- 8.4 Europe Anti-Peptic Ulcer Drugs Market Size by Country
- 8.4.1 Europe Anti-Peptic Ulcer Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Anti-Peptic Ulcer Drugs Market Size by Country (2021-2026)
- 8.4.3 Europe Anti-Peptic Ulcer Drugs Market Size by Country (2027-2032)
- 8.4.4 Europe Anti-Peptic Ulcer Drugs Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Anti-Peptic Ulcer Drugs Market Size (2021-2032)
- 9.2 China Anti-Peptic Ulcer Drugs Market Size by Type
- 9.2.1 China Anti-Peptic Ulcer Drugs Market Size by Type (2021-2026)
- 9.2.2 China Anti-Peptic Ulcer Drugs Market Size by Type (2027-2032)
- 9.2.3 China Anti-Peptic Ulcer Drugs Market Share by Type (2021-2032)
- 9.3 China Anti-Peptic Ulcer Drugs Market Size by Application
- 9.3.1 China Anti-Peptic Ulcer Drugs Market Size by Application (2021-2026)
- 9.3.2 China Anti-Peptic Ulcer Drugs Market Size by Application (2027-2032)
- 9.3.3 China Anti-Peptic Ulcer Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Anti-Peptic Ulcer Drugs Market Size (2021-2032)
- 10.2 Asia Anti-Peptic Ulcer Drugs Market Size by Type
- 10.2.1 Asia Anti-Peptic Ulcer Drugs Market Size by Type (2021-2026)
- 10.2.2 Asia Anti-Peptic Ulcer Drugs Market Size by Type (2027-2032)
- 10.2.3 Asia Anti-Peptic Ulcer Drugs Market Share by Type (2021-2032)
- 10.3 Asia Anti-Peptic Ulcer Drugs Market Size by Application
- 10.3.1 Asia Anti-Peptic Ulcer Drugs Market Size by Application (2021-2026)
- 10.3.2 Asia Anti-Peptic Ulcer Drugs Market Size by Application (2027-2032)
- 10.3.3 Asia Anti-Peptic Ulcer Drugs Market Share by Application (2021-2032)
- 10.4 Asia Anti-Peptic Ulcer Drugs Market Size by Country
- 10.4.1 Asia Anti-Peptic Ulcer Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Anti-Peptic Ulcer Drugs Market Size by Country (2021-2026)
- 10.4.3 Asia Anti-Peptic Ulcer Drugs Market Size by Country (2027-2032)
- 10.4.4 Asia Anti-Peptic Ulcer Drugs Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Anti-Peptic Ulcer Drugs Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Type
- 11.2.1 South America, Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Anti-Peptic Ulcer Drugs Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Application
- 11.3.1 South America, Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Anti-Peptic Ulcer Drugs Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country
- 11.4.1 South America, Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Anti-Peptic Ulcer Drugs Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst